Akebia Therapeutics (AKBA) Income towards Parent Company (2013 - 2026)
Akebia Therapeutics (AKBA) reported Income towards Parent Company of -$8.91 million for Q2 2026, compared with $247,000 a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Income towards Parent Company (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Akebia Therapeutics' Income towards Parent Company came in at -$29.67 million; for FY2025, it came in at -$5.35 million.
- By year, Income towards Parent Company came in at -$69.41 million in FY2024, -$51.93 million in FY2023, -$94.23 million in FY2022 and -$282.02 million in FY2021.
- Five-year quarterly Income towards Parent Company spans a low of -$69.86 million in Q4 2021 and a high of $29.45 million in Q2 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$9.05 million (Q1 2026), -$12.24 million (Q4 2025) and $540,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.91 Mn |
| Mar 31, 2026 | -9.05 Mn |
| Dec 31, 2025 | -12.24 Mn |
| Sep 30, 2025 | 540,000.00 |
| Jun 30, 2025 | 247,000.00 |
| Mar 31, 2025 | 6.11 Mn |
| Dec 31, 2024 | -22.80 Mn |
| Sep 30, 2024 | -20.04 Mn |
| Jun 30, 2024 | -8.58 Mn |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | 614,000.00 |
| Sep 30, 2023 | -14.49 Mn |
| Jun 30, 2023 | -11.17 Mn |
| Mar 31, 2023 | -26.88 Mn |
| Dec 31, 2022 | -6.07 Mn |
| Sep 30, 2022 | -54.10 Mn |
| Jun 30, 2022 | 29.45 Mn |
| Mar 31, 2022 | -63.51 Mn |
| Dec 31, 2021 | -69.86 Mn |
| Sep 30, 2021 | -59.54 Mn |
API Access
Akebia Therapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();